Tags

Type your tag names separated by a space and hit enter

The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome.
Eur J Intern Med. 2010 Oct; 21(5):389-92.EJ

Abstract

BACKGROUND AND AIMS

Celiac disease shares several symptoms which constitute some of the ROME criteria used for the diagnosis of irritable bowel syndrome (IBS), and as such many patients with underlying Celiac disease may be mistakenly diagnosed as having IBS. The aim of the present study was to determine the prevalence of Celiac disease in patients with IBS fulfilling ROME III criteria.

MATERIALS AND METHODS

Patients who fulfilled ROME III criteria for irritable bowel syndrome were screened for Celiac disease using the Biocard(TM) Celiac Disease Stick test, and patients who tested positive had their serum samples analyzed for antigliadin IgA and IgG, and anti-tissue transglutaminase IgA antibodies. Patients with detectable antibody levels underwent endoscopic duodenal biopsy to confirm a diagnosis of Celiac disease.

RESULTS

Two of 100 patients who were diagnosed as having irritable bowel syndrome as per the Roma III criteria were found to have elevated levels of serum antigliadin IgA and IgG, and anti-tissue transglutaminase IgA antibodies, with histological evidence of Celiac disease on examination of duodenal biopsy. Both patients were started on a gluten-free diet, showing significant improvement in their symptoms on follow-up.

CONCLUSIONS

Celiac disease is a common finding among patients labeled as IBS. Celiac disease must be considered in differential diagnosis of IBS especially in the therapy refractory group.

Authors+Show Affiliations

Department of Gastroenterology, Ankara University Medical School, Ankara, Turkey.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

20816591

Citation

Korkut, Esin, et al. "The Prevalence of Celiac Disease in Patients Fulfilling Rome III Criteria for Irritable Bowel Syndrome." European Journal of Internal Medicine, vol. 21, no. 5, 2010, pp. 389-92.
Korkut E, Bektas M, Oztas E, et al. The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome. Eur J Intern Med. 2010;21(5):389-92.
Korkut, E., Bektas, M., Oztas, E., Kurt, M., Cetinkaya, H., & Ozden, A. (2010). The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome. European Journal of Internal Medicine, 21(5), 389-92. https://doi.org/10.1016/j.ejim.2010.06.004
Korkut E, et al. The Prevalence of Celiac Disease in Patients Fulfilling Rome III Criteria for Irritable Bowel Syndrome. Eur J Intern Med. 2010;21(5):389-92. PubMed PMID: 20816591.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome. AU - Korkut,Esin, AU - Bektas,Mehmet, AU - Oztas,Erkin, AU - Kurt,Mevlut, AU - Cetinkaya,Hulya, AU - Ozden,Ali, Y1 - 2010/07/14/ PY - 2010/03/22/received PY - 2010/05/30/revised PY - 2010/06/09/accepted PY - 2010/9/7/entrez PY - 2010/9/8/pubmed PY - 2010/12/31/medline SP - 389 EP - 92 JF - European journal of internal medicine JO - Eur J Intern Med VL - 21 IS - 5 N2 - BACKGROUND AND AIMS: Celiac disease shares several symptoms which constitute some of the ROME criteria used for the diagnosis of irritable bowel syndrome (IBS), and as such many patients with underlying Celiac disease may be mistakenly diagnosed as having IBS. The aim of the present study was to determine the prevalence of Celiac disease in patients with IBS fulfilling ROME III criteria. MATERIALS AND METHODS: Patients who fulfilled ROME III criteria for irritable bowel syndrome were screened for Celiac disease using the Biocard(TM) Celiac Disease Stick test, and patients who tested positive had their serum samples analyzed for antigliadin IgA and IgG, and anti-tissue transglutaminase IgA antibodies. Patients with detectable antibody levels underwent endoscopic duodenal biopsy to confirm a diagnosis of Celiac disease. RESULTS: Two of 100 patients who were diagnosed as having irritable bowel syndrome as per the Roma III criteria were found to have elevated levels of serum antigliadin IgA and IgG, and anti-tissue transglutaminase IgA antibodies, with histological evidence of Celiac disease on examination of duodenal biopsy. Both patients were started on a gluten-free diet, showing significant improvement in their symptoms on follow-up. CONCLUSIONS: Celiac disease is a common finding among patients labeled as IBS. Celiac disease must be considered in differential diagnosis of IBS especially in the therapy refractory group. SN - 1879-0828 UR - https://www.unboundmedicine.com/medline/citation/20816591/The_prevalence_of_celiac_disease_in_patients_fulfilling_Rome_III_criteria_for_irritable_bowel_syndrome_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0953-6205(10)00113-5 DB - PRIME DP - Unbound Medicine ER -